نتائج البحث

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy

• Authors : Socie, G; Barba, P; Barlev, A

Subjects: Medicin och hälsovetenskap

• Source: Bone marrow transplantation. 59(1):52-58

تفاصيل العنوان

Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage

• Authors : Jons, D; Grut, V; Bergstrom, T

Subjects: Medicin och hälsovetenskap

• Source: Journal of neurology, neurosurgery, and psychiatry. 95(4):325-332

تفاصيل العنوان

EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes.

• Authors : Law, Nancy; Logan, Cathy; Taplitz, Randy

Subjects: EBV-specific cytotoxic T-cells; Epstein–Barr virus; allogeneic transplant

• Source: Viruses. 16(8)

تفاصيل العنوان

Decoding Critical Targets and Signaling Pathways in EBV-Mediated Diseases Using Large Language Models.

• Authors : Yu, Jingwen¹ (AUTHOR) ; Wang, Yaohao¹ (AUTHOR) ; Wang, Haidong¹ (AUTHOR)

Subjects: *LANGUAGE models; *DIFFUSE large B-cell lymphomas; *EPSTEIN-Barr virus diseases

• Source: Viruses (1999-4915). Nov2024, Vol. 16 Issue 11, p1660. 17p.

تفاصيل العنوان

脾脏 EBV 阳性炎性假瘤样滤泡树突细胞肉瘤 1 例并文献复习.

• Authors : 高玉霞¹; 梁奋雄¹; 陆骊工^1,2

• Source: Journal of Modern Medicine & Health. 12/30/2024, Vol. 40 Issue 24, p4214-4217. 4p.

تفاصيل العنوان

Epstein Barr Virus (EBV) Latent Membrane Protein 1 (LMP-1) Regulates Functional Markers in Intermediate and Non-Classical Monocytes.

• Authors : Moyano, Agustina¹ (AUTHOR) ; Colado, Ana² (AUTHOR) ; Amarillo, María Eugenia¹ (AUTHOR)

• Source: Cancers. Dec2024, Vol. 16 Issue 24, p4169. 11p.

تفاصيل العنوان

Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

• Authors : Argirion, I; Pfeiffer, RM; Proietti, C

Subjects: Medicin och hälsovetenskap

• Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 32(5):687-696

تفاصيل العنوان

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

• Source: Phase 2 Trial of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas

تفاصيل العنوان

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

• Source: A Phase 1/2 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350

تفاصيل العنوان

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

• Authors : Children's Hospital of Philadelphia; Medical College of Wisconsin; Nationwide Children's Hospital ...

• Source: A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection With Related Donor EBV Cytotoxic T-Lymphocytes in

تفاصيل العنوان